64 related articles for article (PubMed ID: 25808816)
1. Ketoconazole Treatment Decreases the Viability of Immortalized Pituitary Cell Lines Associated with an Increased Expression of Apoptosis-Related Genes and Cell Cycle Inhibitors.
Guzzo MF; Carvalho LR; Bronstein MD
J Neuroendocrinol; 2015 Jul; 27(7):616-23. PubMed ID: 25808816
[TBL] [Abstract][Full Text] [Related]
2. Effects of Ketoconazole on ACTH-Producing and Non-ACTH-Producing Neuroendocrine Tumor Cells.
Herrera-Martínez AD; Feelders RA; de Herder WW; Castaño JP; Gálvez Moreno MÁ; Dogan F; van Dungen R; van Koetsveld P; Hofland LJ
Horm Cancer; 2019 Jun; 10(2-3):107-119. PubMed ID: 31102172
[TBL] [Abstract][Full Text] [Related]
3. ACTH response to corticotropin releasing hormone in Cushing's disease before and after ketoconazole: in vivo and in vitro studies.
Boscaro M; Sonino N; Rampazzo A; Menegus AM; Mantero F
Horm Metab Res Suppl; 1987; 16():60-2. PubMed ID: 2832292
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
5. Effects of Imatinib Combined With Everolimus on Mouse Pituitary Tumor Cell AtT-20.
Wang W; Lin Y; Qu X; Meng L; Yang J
Altern Ther Health Med; 2023 Jan; 29(1):238-244. PubMed ID: 36150015
[TBL] [Abstract][Full Text] [Related]
6. Aphidicolin inhibits cell proliferation via the p53-GADD45β pathway in AtT-20 cells.
Kageyama K; Sugiyama A; Murasawa S; Asari Y; Niioka K; Oki Y; Daimon M
Endocr J; 2015; 62(7):645-54. PubMed ID: 25948499
[TBL] [Abstract][Full Text] [Related]
7. Lycopene and beta-carotene induce growth inhibition and proapoptotic effects on ACTH-secreting pituitary adenoma cells.
Haddad NF; Teodoro AJ; Leite de Oliveira F; Soares N; de Mattos RM; Hecht F; Dezonne RS; Vairo L; Goldenberg RC; Gomes FC; de Carvalho DP; Gadelha MR; Nasciutti LE; Miranda-Alves L
PLoS One; 2013; 8(5):e62773. PubMed ID: 23667519
[TBL] [Abstract][Full Text] [Related]
8. Drugs in the medical treatment of Cushing's syndrome.
Schteingart DE
Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
[TBL] [Abstract][Full Text] [Related]
9. Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo.
Schaaf C; Shan B; Buchfelder M; Losa M; Kreutzer J; Rachinger W; Stalla GK; Schilling T; Arzt E; Perone MJ; Renner U
Endocr Relat Cancer; 2009 Dec; 16(4):1339-50. PubMed ID: 19726538
[TBL] [Abstract][Full Text] [Related]
10. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
11. Ketoconazole potentiates the antitumor effects of nocodazole: In vivo therapy for human tumor xenografts in nude mice.
Wang YJ; Jeng JH; Chen RJ; Tseng H; Chen LC; Liang YC; Lin CH; Chen CH; Chu JS; Ho WL; Ho YS
Mol Carcinog; 2002 Aug; 34(4):199-210. PubMed ID: 12203371
[TBL] [Abstract][Full Text] [Related]
12. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
13. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB
Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145.
Yun JM; Kweon MH; Kwon H; Hwang JK; Mukhtar H
Carcinogenesis; 2006 Jul; 27(7):1454-64. PubMed ID: 16497706
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
16. Use of ketoconazole in the treatment of Cushing's syndrome.
Loli P; Berselli ME; Tagliaferri M
J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
[TBL] [Abstract][Full Text] [Related]
17. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
18. Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function.
Gentilin E; Tagliati F; Terzolo M; Zoli M; Lapparelli M; Minoia M; Ambrosio MR; Degli Uberti EC; Zatelli MC
J Endocrinol; 2013 Sep; 218(3):275-85. PubMed ID: 23814013
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid as a novel medical therapy for Cushing's disease in dogs.
Castillo V; Giacomini D; Páez-Pereda M; Stalla J; Labeur M; Theodoropoulou M; Holsboer F; Grossman AB; Stalla GK; Arzt E
Endocrinology; 2006 Sep; 147(9):4438-44. PubMed ID: 16740975
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells.
Tong WG; Ding XZ; Talamonti MS; Bell RH; Adrian TE
Anticancer Drugs; 2007 Jun; 18(5):535-41. PubMed ID: 17414622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
